Skip to main content
Clinical Trials/NCT03603626
NCT03603626
Withdrawn
N/A

Effect of Preemptive Pregabalin for Post-operative Pain Relief in Myringoplasty

Dhulikhel Hospital1 site in 1 countrySeptember 2015

Overview

Phase
N/A
Intervention
Placebo oral capsule
Conditions
Post-operative Analgesia
Sponsor
Dhulikhel Hospital
Locations
1
Primary Endpoint
This study is constructed to determine whether the use of preemptive single dose oral pregabalin would decrease post-operative pain in patient undergoing myringoplasty.
Status
Withdrawn
Last Updated
7 years ago

Overview

Brief Summary

The aim of this study was to investigate the effect of preemptive pregabalin on post-operative pain reduction after myringoplasty.

Detailed Description

Patient were randomly assigned to one of two groups with 30 participants each by lottery method. Pregabalin group received capsule Pregabalin 150mg and Placebo group were given Vitamin B capsule 1 hour prior to surgery. All patients underwent endoscopic myringoplasty with tragal cartilage and perichondrium graft. Surgical procedure was done under local anesthesia. 5ml of 2% xylocaine with 1:2,00,000 adrenalin was infiltrated in the four quadrants of external ear canal and on tragus. Around 2cm incision was given on canal surface of tragus and around 2cm x 1.5cm cartilage- perichondrium graft was obtained. The skin was closed with 4/0 prolene interrupted suture. Using rigid Hopkins II 0-degree endoscope (Karl Storz) with 4-millimeter diameter and 18 centimeters in length, margin of perforation was refreshed. Gelatin sponge was kept in the middle ear and cartilage perichondrium graft placed. Canal was then packed with gelatin soaked in ciprofloxacin ear drops followed by ribbon pack medicated with soframycin. Small dressing was applied over it. Post-operative pain severity was assessed with VAS scale at 6, 12, 24, 48 hours. Rescue analgesia is given with Injection Ketorolac (30mg IV) or Tab Flexon (Ibuprofen 400mg + Paracetamol 500mg) whenever the patient required.

Registry
clinicaltrials.gov
Start Date
September 2015
End Date
December 2017
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr Ashish Dhakal

Lecturer, Department of Otolaryngology Head and Neck Surgery

Dhulikhel Hospital

Eligibility Criteria

Inclusion Criteria

  • Cases of Chronic suppurative otitis media (CSOM) inactive planned for endoscopic myringoplasty under local anesthesia,
  • Age \>= 18 years
  • either sex.

Exclusion Criteria

  • Revision cases,
  • Pregnancy or breastfeeding,
  • Known or suspected sensitivity or contraindication to pregabalin,
  • Patient using medication for chronic pain,
  • History of seizure disorder,
  • Mental retardation.

Arms & Interventions

Placebo

Intervention: Placebo oral capsule

Preemptive pregabalin

Intervention: Pregabalin 150mg

Outcomes

Primary Outcomes

This study is constructed to determine whether the use of preemptive single dose oral pregabalin would decrease post-operative pain in patient undergoing myringoplasty.

Time Frame: At 6, 12, 24, 48 hours in postoperative period

Post-operative pain severity was assessed with Visual Analogue Scale (VAS). It's a 10cm scale in which 0 represents no pain at all and 10 represents the worst pain imaginable. VAS score was compared between 2 groups at 6, 12, 24, 48 hrs post-operative period. This would show if there is any change in pain score between groups using pregabalin or placebo in the given time frame.

Study Sites (1)

Loading locations...

Similar Trials